400
Participants
Start Date
April 30, 2024
Primary Completion Date
December 1, 2024
Study Completion Date
February 15, 2025
Anti Tuberculosis Drug
"1. Estimate the prevalence of prescribing drugs known to have major drug-drug interaction(s) with anti-tuberculous drugs among Kasr Alainy tuberculous patients.~2. Assess the outcome of prescribing drugs known to have major drug-drug interaction(s) with anti-tuberculous drugs among Kasr Alainy tuberculous patients (response to treatment and the prevalence of life-threatening events)."
RECRUITING
Omnia Azmy Nabeh, Cairo
Cairo University
OTHER